NorthRock Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Sell
9,753
-1,746
-15% -$88.6K 0.01% 445
2026
Q1
$613K Sell
11,499
-228
-2% -$13.4K 0.01% 381
2025
Q4
$729K Hold
11,727
0.01% 316
2025
Q3
$705K Buy
11,727
+210
+2% +$12.8K 0.01% 427
2025
Q2
$721K Sell
11,517
-1,598
-12% -$96K 0.02% 311
2025
Q1
$789K Buy
13,115
+1,923
+17% +$119K 0.03% 245
2024
Q4
$653K Sell
11,192
-38
-0.3% -$2.26K 0.02% 287
2024
Q3
$665K Sell
11,230
-6
-0.1% -$343 0.02% 297
2024
Q2
$630K Buy
11,236
+154
+1% +$8.62K 0.02% 289
2024
Q1
$649K Sell
11,082
-1,618
-13% -$91.4K 0.02% 287
2023
Q4
$685K Buy
12,700
+6,944
+121% +$339K 0.03% 249
2023
Q3
$279K Buy
5,756
+14
+0.2% +$744 0.03% 251
2023
Q2
$324K Sell
5,742
-1,416
-20% -$78K 0.04% 201
2023
Q1
$386K Hold
7,158
0.04% 180
2022
Q4
$376K Sell
7,158
-17
-0.2% -$863 0.04% 200
2022
Q3
$338K Buy
7,175
+17
+0.2% +$882 0.04% 184
2022
Q2
$361K Sell
7,158
-610
-8% -$33.2K 0.04% 192
2022
Q1
$474K Sell
7,768
-4,975
-39% -$297K 0.04% 176
2021
Q4
$839K Buy
12,743
+949
+8% +$60.8K 0.06% 115
2021
Q3
$800K Sell
11,794
-60,338
-84% -$3.85M 0.07% 111
2021
Q2
$723K Buy
72,132
+60,108
+500% +$3.48M 0.06% 106
2021
Q1
$662K Sell
12,024
-720
-6% -$39.9K 0.06% 104
2020
Q4
$695K Sell
12,744
-444
-3% -$23.2K 0.07% 103
2020
Q3
$659K Sell
13,188
-3,762
-22% -$182K 0.07% 100
2020
Q2
$748K Sell
16,950
-2,190
-11% -$93.6K 0.09% 91
2020
Q1
$719K Buy
19,140
+7,266
+61% +$306K 0.1% 93
2019
Q4
$523K Sell
11,874
-138
-1% -$5.8K 0.06% 148
2019
Q3
$495K Buy
+12,012
New +$492K 0.07% 128

Other funds holding IHI

NorthRock Partners's IHI Position: Q2 2026 in Review

NorthRock Partners reduced its iShares US Medical Devices ETF (IHI) stake by 15% in Q2 2026, selling an estimated $88.6K and leaving 9,753 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #445.

NorthRock Partners first reported a position in IHI in Q3 2019 and has held it in 28 quarters since. The position peaked at $839K in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • NorthRock Partners held 9,753 shares of iShares US Medical Devices ETF worth $482K as of Q2 2026.
  • NorthRock Partners sold 1,746 iShares US Medical Devices ETF shares in Q2 2026, an estimated $88.6K.
  • iShares US Medical Devices ETF made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #445 holding.
  • NorthRock Partners first reported a position in iShares US Medical Devices ETF in Q3 2019 and has held it in 28 quarters since.
  • NorthRock Partners's iShares US Medical Devices ETF position peaked at $839K in Q4 2021.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.